CEFUROXIME

CEFUROXIME was reported 11516 times

CEFUROXIME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY VASCULITIS 188 0.3494
1 TOTAL LUNG CAPACITY ABNORMAL 116 0.2982
2 TRIMETHYLAMINURIA 11 0.2683
3 MASTITIS BACTERIAL 13 0.2031
4 CAPILLARITIS 54 0.1957
5 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 13 0.1940
6 FOETAL ANAEMIA 25 0.1908
7 SPIROMETRY ABNORMAL 112 0.1873
8 MICROVILLOUS INCLUSION DISEASE 12 0.1600
9 MITE ALLERGY 101 0.1542
10 RETINAL INFARCTION 30 0.1220
11 MYCOTIC ALLERGY 100 0.1170
12 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 84 0.1146
13 NEURITIS 172 0.1113
14 PROBIOTIC THERAPY 11 0.1111
15 CONGENITAL PNEUMONIA 10 0.1053
16 DUST ALLERGY 102 0.1040
17 CRYPTITIS 13 0.0935
18 MACULAR DETACHMENT 20 0.0826
19 CONGENITAL CYTOMEGALOVIRUS INFECTION 14 0.0824
20 PAROPHTHALMIA 19 0.0798
21 POSITIVE AIRWAY PRESSURE THERAPY 23 0.0788
22 CONJUNCTIVITIS ALLERGIC 112 0.0756
23 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 141 0.0691
24 SPINAL MUSCULAR ATROPHY 18 0.0667
25 RESPIRATORY SYMPTOM 182 0.0639
26 SOFT TISSUE MASS 29 0.0628
27 PYROGLUTAMIC ACIDOSIS 24 0.0605
28 DEAFNESS CONGENITAL 12 0.0597
29 CONGENITAL TRICUSPID VALVE INCOMPETENCE 10 0.0500
30 PERIVENTRICULAR LEUKOMALACIA 14 0.0495
31 RENAL GRAFT INFECTION 11 0.0474
32 STOMA CLOSURE 14 0.0450
33 APOPTOSIS 13 0.0421
34 NORMOCHROMIC NORMOCYTIC ANAEMIA 124 0.0412
35 RETINAL TOXICITY 40 0.0388
36 ANTERIOR CHAMBER INFLAMMATION 23 0.0387
37 MERYCISM 11 0.0385
38 FORCED EXPIRATORY VOLUME DECREASED 107 0.0377
39 PNEUMOCOCCAL SEPSIS 22 0.0335
40 THERAPEUTIC PRODUCT CROSS-REACTIVITY 29 0.0325
41 OESOPHAGEAL PERFORATION 27 0.0324
42 PULMONARY ALVEOLAR HAEMORRHAGE 177 0.0315
43 CORNEAL DEPOSITS 23 0.0309
44 NEUROLOGICAL SYMPTOM 173 0.0302
45 RESPIRATORY TRACT INFECTION BACTERIAL 15 0.0301
46 DYSBIOSIS 24 0.0292
47 MOTOR NEURONE DISEASE 14 0.0287
48 TYPE IV HYPERSENSITIVITY REACTION 77 0.0281
49 PNEUMONIA MYCOPLASMAL 22 0.0276
50 VACCINATION SITE PAIN 15 0.0261
51 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 13 0.0254
52 REBOUND ACID HYPERSECRETION 77 0.0254
53 SEPSIS SYNDROME 12 0.0239
54 WHITE MATTER LESION 30 0.0237
55 MULTIMORBIDITY 28 0.0234
56 OCULAR TOXICITY 25 0.0226
57 DELIVERY 14 0.0212
58 CORNEAL OEDEMA 46 0.0205
59 CONJUNCTIVAL OEDEMA 21 0.0204
60 NEPHROGENIC ANAEMIA 93 0.0201
61 CORNEAL OPACITY 27 0.0198
62 PSEUDOMEMBRANOUS COLITIS 44 0.0197
63 LUNG CONSOLIDATION 54 0.0193
64 TOXIC ANTERIOR SEGMENT SYNDROME 21 0.0192
65 ROTAVIRUS INFECTION 11 0.0191
66 ARTERIOSCLEROSIS CORONARY ARTERY 125 0.0188
67 OBSTRUCTIVE AIRWAYS DISORDER 209 0.0188
68 EROSIVE DUODENITIS 15 0.0187
69 SUPERINFECTION 28 0.0187
70 ALLERGIC OEDEMA 12 0.0185
71 HYPERPARATHYROIDISM SECONDARY 46 0.0183
72 ABSCESS NECK 12 0.0178
73 VASCULITIS 206 0.0177
74 MATERNAL EXPOSURE DURING DELIVERY 17 0.0172
75 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 18 0.0169
76 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 26 0.0169
77 PATENT DUCTUS ARTERIOSUS 66 0.0166
78 SERRATIA INFECTION 12 0.0161
79 ISCHAEMIC CEREBRAL INFARCTION 18 0.0155
80 FULL BLOOD COUNT ABNORMAL 163 0.0154
81 PREMATURE RUPTURE OF MEMBRANES 36 0.0149
82 TOXOPLASMOSIS 16 0.0148
83 LYMPHADENECTOMY 14 0.0143
84 SOMATIC SYMPTOM DISORDER 15 0.0139
85 TRANSPLANT FAILURE 34 0.0139
86 HYPOPYON 11 0.0133
87 MACULAR OEDEMA 74 0.0132
88 ACINETOBACTER INFECTION 14 0.0128
89 KOUNIS SYNDROME 29 0.0128
90 BRONCHIAL DISORDER 19 0.0122
91 RESUSCITATION 20 0.0121
92 LISTERIOSIS 13 0.0118
93 ARTERIOSCLEROSIS 110 0.0117
94 RETINAL OEDEMA 22 0.0115
95 ASPERGILLOSIS 15 0.0115
96 CLOSTRIDIUM TEST POSITIVE 25 0.0113
97 ACQUIRED HAEMOPHILIA 11 0.0110
98 OESOPHAGEAL SPASM 20 0.0108
99 ORAL MUCOSA EROSION 13 0.0106
100 COGWHEEL RIGIDITY 11 0.0105
101 NOSOCOMIAL INFECTION 23 0.0104
102 OPTIC ATROPHY 17 0.0104
103 SYSTEMIC INFECTION 17 0.0102
104 RESTRICTIVE PULMONARY DISEASE 12 0.0102
105 ISCHAEMIC HEPATITIS 14 0.0102
106 CONTINUOUS HAEMODIAFILTRATION 10 0.0102
107 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 173 0.0102
108 DEAFNESS BILATERAL 17 0.0100
109 PULMONARY FIBROSIS 188 0.0098
110 EXOPHTHALMOS 21 0.0098
111 SPUTUM INCREASED 21 0.0097
112 PRODUCT MONITORING ERROR 14 0.0097
113 LIGAMENT INJURY 11 0.0097
114 TYPE I HYPERSENSITIVITY 34 0.0097
115 ESCHERICHIA URINARY TRACT INFECTION 41 0.0096
116 QUADRIPARESIS 16 0.0096
117 STENOSIS 18 0.0096
118 CLOSTRIDIUM DIFFICILE COLITIS 100 0.0094
119 LIP ULCERATION 11 0.0094
120 GRANULOMATOSIS WITH POLYANGIITIS 11 0.0091
121 END STAGE RENAL DISEASE 166 0.0091
122 INFLAMMATORY MARKER INCREASED 45 0.0091
123 CYSTOID MACULAR OEDEMA 17 0.0090
124 LINEAR IGA DISEASE 15 0.0090
125 INCREASED BRONCHIAL SECRETION 23 0.0090
126 HAEMOPTYSIS 246 0.0088
127 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 29 0.0088
128 PNEUMONIA KLEBSIELLA 16 0.0087
129 NODULE 111 0.0085
130 FANCONI SYNDROME 12 0.0085
131 ENDOPHTHALMITIS 50 0.0083
132 TOXIC EPIDERMAL NECROLYSIS 123 0.0081
133 RALES 47 0.0081
134 RETINAL DETACHMENT 72 0.0078
135 LOW BIRTH WEIGHT BABY 61 0.0077
136 CHRONIC KIDNEY DISEASE 573 0.0075
137 CHEST X-RAY ABNORMAL 23 0.0075
138 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 182 0.0071
139 ENTHESOPATHY 11 0.0070
140 MEGACOLON 11 0.0070
141 RETINOPATHY 26 0.0070
142 RASH MACULO-PAPULAR 154 0.0069
143 HYPERSENSITIVITY VASCULITIS 18 0.0068
144 INFUSION SITE DISCHARGE 12 0.0068
145 CARDIOVASCULAR INSUFFICIENCY 11 0.0068
146 FOETAL GROWTH RESTRICTION 41 0.0067
147 CHOLESTATIC LIVER INJURY 15 0.0067
148 ANAPHYLACTIC SHOCK 170 0.0066
149 CLOSTRIDIAL INFECTION 22 0.0065
150 RENAL INJURY 193 0.0065
151 MACULOPATHY 23 0.0065
152 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 50 0.0064
153 OSTEITIS 16 0.0063
154 URINARY TRACT INFECTION BACTERIAL 16 0.0063
155 BRONCHOSPASM 90 0.0063
156 HYDRONEPHROSIS 47 0.0063
157 PATHOGEN RESISTANCE 57 0.0062
158 CLOSTRIDIUM DIFFICILE INFECTION 136 0.0062
159 NEONATAL RESPIRATORY DISTRESS SYNDROME 22 0.0062
160 HYPOTHYROIDISM 198 0.0062
161 DUODENITIS 19 0.0062
162 INTESTINAL ISCHAEMIA 34 0.0062
163 KLEBSIELLA INFECTION 31 0.0061
164 STAPHYLOCOCCAL SEPSIS 30 0.0061
165 OTITIS MEDIA 20 0.0060
166 PREMATURE DELIVERY 95 0.0060
167 LOBAR PNEUMONIA 11 0.0059
168 PREMATURE BABY 176 0.0058
169 MULTI-ORGAN FAILURE 101 0.0058
170 HYPOPROTEINAEMIA 11 0.0058
171 TUBULOINTERSTITIAL NEPHRITIS 108 0.0058
172 ATRIAL TACHYCARDIA 12 0.0057
173 TACHYPNOEA 77 0.0057
174 HYPERLACTACIDAEMIA 15 0.0056
175 ESCHERICHIA INFECTION 46 0.0056
176 ANAPHYLACTIC REACTION 303 0.0055
177 LIPOMA 14 0.0054
178 OESOPHAGEAL PAIN 21 0.0053
179 HYPOXIA 183 0.0052
180 OLIGURIA 32 0.0051
181 VENOUS THROMBOSIS 20 0.0051
182 HEPATOSPLENOMEGALY 13 0.0051
183 PARANASAL SINUS DISCOMFORT 19 0.0050
184 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
185 ACUTE PSYCHOSIS 12 0.0048
186 VASCULAR DEVICE INFECTION 22 0.0048
187 RESPIRATORY ACIDOSIS 19 0.0048
188 TALIPES 15 0.0048
189 TACHYARRHYTHMIA 12 0.0048
190 PRODUCTIVE COUGH 229 0.0048
191 WHEEZING 281 0.0047
192 FAECAL CALPROTECTIN INCREASED 15 0.0047
193 RHINALGIA 13 0.0047
194 CUTANEOUS VASCULITIS 17 0.0047
195 ENDOTRACHEAL INTUBATION 13 0.0046
196 LUNG DISORDER 226 0.0046
197 HEPATITIS TOXIC 12 0.0046
198 DERMATITIS EXFOLIATIVE GENERALISED 16 0.0046
199 NORMAL NEWBORN 25 0.0046
200 LYMPHOCYTE COUNT INCREASED 15 0.0046
201 ATELECTASIS 44 0.0045
202 LIVE BIRTH 38 0.0045
203 THROAT CLEARING 17 0.0045
204 BRONCHITIS CHRONIC 11 0.0045
205 FIBRIN D DIMER INCREASED 16 0.0045
206 BACTERIAL TEST POSITIVE 10 0.0045
207 IRON DEFICIENCY 20 0.0044
208 ANHEDONIA 116 0.0044
209 DEMYELINATION 18 0.0044
210 RENAL FAILURE 583 0.0044
211 ANGIOEDEMA 193 0.0044
212 LYMPHOEDEMA 30 0.0043
213 METABOLIC ENCEPHALOPATHY 13 0.0043
214 RASH MORBILLIFORM 12 0.0043
215 SPUTUM DISCOLOURED 41 0.0043
216 COLITIS ISCHAEMIC 29 0.0043
217 HYPOVENTILATION 14 0.0043
218 DEAFNESS NEUROSENSORY 14 0.0043
219 RETINAL DISORDER 11 0.0042
220 CONJUNCTIVAL HYPERAEMIA 15 0.0042
221 NEPHRITIS 14 0.0042
222 ERYSIPELAS 21 0.0042
223 MYOCARDIAL ISCHAEMIA 47 0.0041
224 UROSEPSIS 38 0.0041
225 DIVERTICULUM INTESTINAL 18 0.0041
226 RENAL TUBULAR NECROSIS 40 0.0041
227 CARDIOMEGALY 50 0.0041
228 ATRIAL SEPTAL DEFECT 34 0.0041
229 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
230 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 189 0.0039
231 PYELONEPHRITIS 34 0.0039
232 ACUTE PULMONARY OEDEMA 22 0.0039
233 ENTERITIS 25 0.0039
234 SYNOVIAL CYST 18 0.0039
235 ANXIETY DISORDER 13 0.0039
236 AORTIC ARTERIOSCLEROSIS 10 0.0039
237 PLANTAR FASCIITIS 13 0.0039
238 TOXIC SKIN ERUPTION 39 0.0039
239 FEAR 104 0.0039
240 DIVERTICULUM 27 0.0038
241 METABOLIC DISORDER 22 0.0038
242 BLOOD ALBUMIN DECREASED 30 0.0038
243 GESTATIONAL DIABETES 18 0.0038
244 CIRCULATORY COLLAPSE 64 0.0038
245 ACUTE KIDNEY INJURY 572 0.0037
246 DISEASE COMPLICATION 17 0.0037
247 CREPITATIONS 11 0.0037
248 VENTRICULAR SEPTAL DEFECT 21 0.0037
249 FOETAL EXPOSURE DURING PREGNANCY 293 0.0036
250 LYME DISEASE 12 0.0036
251 SWOLLEN TONGUE 110 0.0035
252 ELECTROLYTE IMBALANCE 40 0.0034
253 STEVENS-JOHNSON SYNDROME 76 0.0034
254 FACIAL PARESIS 12 0.0034
255 INFUSION SITE HAEMORRHAGE 11 0.0033
256 GENERALISED ERYTHEMA 19 0.0033
257 CEREBRAL ISCHAEMIA 17 0.0033
258 ATRIOVENTRICULAR BLOCK SECOND DEGREE 10 0.0033
259 LEUKOCYTOSIS 59 0.0033
260 EOSINOPHILIA 57 0.0032
261 HYPOVOLAEMIA 19 0.0032
262 HYPOALBUMINAEMIA 25 0.0032
263 AUTOIMMUNE HAEMOLYTIC ANAEMIA 11 0.0032
264 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
265 METABOLIC ACIDOSIS 101 0.0032
266 FACE OEDEMA 53 0.0031
267 PULSELESS ELECTRICAL ACTIVITY 13 0.0031
268 LIP OEDEMA 13 0.0031
269 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 218 0.0031
270 LUNG INFILTRATION 27 0.0031
271 NECROSIS 17 0.0031
272 PURPURA 27 0.0030
273 JAUNDICE 82 0.0030
274 MONOCYTE COUNT INCREASED 11 0.0030
275 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 15 0.0030
276 THROMBOCYTOSIS 11 0.0030
277 MULTIPLE ORGAN DYSFUNCTION SYNDROME 85 0.0030
278 ORGAN FAILURE 12 0.0030
279 COLITIS MICROSCOPIC 14 0.0030
280 PATHOLOGICAL FRACTURE 15 0.0030
281 RETINAL HAEMORRHAGE 21 0.0029
282 ABDOMINAL ABSCESS 13 0.0029
283 BLOOD CREATINE INCREASED 13 0.0029
284 TRANSAMINASES INCREASED 65 0.0029
285 WOUND INFECTION 32 0.0029
286 BRONCHOPNEUMONIA 10 0.0029
287 EXPOSURE DURING PREGNANCY 181 0.0029
288 ENTEROCOCCAL INFECTION 14 0.0029
289 TONGUE OEDEMA 11 0.0029
290 SYMPTOM RECURRENCE 17 0.0028
291 POLYNEUROPATHY 34 0.0028
292 CARDIOPULMONARY FAILURE 11 0.0028
293 SMALL FOR DATES BABY 14 0.0028
294 MULTIPLE ALLERGIES 22 0.0028
295 PSEUDOMONAS INFECTION 24 0.0028
296 TENSION HEADACHE 12 0.0028
297 ACUTE RESPIRATORY DISTRESS SYNDROME 49 0.0028
298 TROPONIN INCREASED 21 0.0028
299 ASTHMA 311 0.0027
300 CANDIDIASIS 11 0.0027
301 ARTERIOSPASM CORONARY 11 0.0027
302 SEPTIC SHOCK 119 0.0027
303 DRUG LEVEL INCREASED 45 0.0027
304 APHTHOUS ULCER 21 0.0027
305 RENAL FAILURE ACUTE 114 0.0027
306 ODYNOPHAGIA 16 0.0027
307 GASTROINTESTINAL INFECTION 24 0.0027
308 CARDIAC MURMUR 23 0.0027
309 CHOLESTASIS 51 0.0027
310 ASCITES 78 0.0027
311 ABDOMINAL TENDERNESS 13 0.0026
312 HYPOTONIA 26 0.0026
313 SEPSIS 290 0.0026
314 DERMATITIS EXFOLIATIVE 13 0.0026
315 INJURY 182 0.0026
316 CARDIOGENIC SHOCK 37 0.0026
317 SHOCK 59 0.0026
318 ACUTE HEPATIC FAILURE 35 0.0026
319 PULMONARY EMBOLISM 242 0.0025
320 PROTHROMBIN TIME PROLONGED 15 0.0025
321 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
322 FOETAL DEATH 13 0.0025
323 HAEMODYNAMIC INSTABILITY 19 0.0025
324 STILLBIRTH 12 0.0025
325 AGRANULOCYTOSIS 46 0.0025
326 ILEUS PARALYTIC 11 0.0025
327 RESPIRATORY TRACT INFECTION 64 0.0025
328 C-REACTIVE PROTEIN INCREASED 89 0.0024
329 HYPERTONIA 14 0.0024
330 SINUS CONGESTION 33 0.0024
331 ANURIA 21 0.0024
332 ASPERGILLUS INFECTION 16 0.0024
333 HEPARIN-INDUCED THROMBOCYTOPENIA 12 0.0024
334 URINE ABNORMALITY 11 0.0024
335 CHOLANGITIS 15 0.0024
336 IMMUNE THROMBOCYTOPENIA 11 0.0024
337 FLUID INTAKE REDUCED 12 0.0024
338 MENINGITIS 16 0.0024
339 SWELLING FACE 156 0.0024
340 SPINAL OSTEOARTHRITIS 21 0.0024
341 CHOLECYSTITIS CHRONIC 16 0.0024
342 CYSTITIS 76 0.0024
343 INFUSION SITE SWELLING 15 0.0024
344 ECONOMIC PROBLEM 36 0.0024
345 PARALYSIS 34 0.0024
346 TOXIC ENCEPHALOPATHY 12 0.0024
347 DRUG-INDUCED LIVER INJURY 74 0.0024
348 PROCEDURAL COMPLICATION 18 0.0023
349 FLANK PAIN 22 0.0023
350 HYPOKALAEMIA 108 0.0023
351 DRUG INTERACTION 371 0.0023
352 GASTROENTERITIS 34 0.0023
353 BRONCHITIS 172 0.0023
354 HYPERAESTHESIA 19 0.0023
355 RENAL IMPAIRMENT 194 0.0023
356 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51 0.0023
357 TENDON DISORDER 15 0.0023
358 TONSILLITIS 12 0.0023
359 MITRAL VALVE INCOMPETENCE 26 0.0023
360 PARTIAL SEIZURES 12 0.0023
361 CYTOMEGALOVIRUS INFECTION 38 0.0023
362 HUMERUS FRACTURE 11 0.0023
363 TOOTH INFECTION 30 0.0023
364 HYPOTHERMIA 23 0.0023
365 SCOLIOSIS 14 0.0023
366 DRUG RESISTANCE 58 0.0023
367 TENDON PAIN 17 0.0022
368 ATRIOVENTRICULAR BLOCK COMPLETE 15 0.0022
369 DIVERTICULITIS 62 0.0022
370 HYPERVOLAEMIA 11 0.0022
371 CHEILITIS 12 0.0022
372 HYDROCEPHALUS 12 0.0022
373 FOREIGN BODY SENSATION IN EYES 14 0.0022
374 CORONARY ARTERY STENOSIS 11 0.0022
375 ORAL DISORDER 16 0.0022
376 DYSPHONIA 127 0.0022
377 EYELID PTOSIS 22 0.0022
378 COAGULOPATHY 36 0.0022
379 MOTOR DYSFUNCTION 22 0.0022
380 IRRITABLE BOWEL SYNDROME 46 0.0021
381 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
382 HYPERBILIRUBINAEMIA 22 0.0021
383 LYMPHOPENIA 30 0.0021
384 SEASONAL ALLERGY 30 0.0021
385 PERIORBITAL OEDEMA 11 0.0021
386 INTRAOCULAR PRESSURE INCREASED 27 0.0021
387 ANAL INCONTINENCE 19 0.0021
388 EYE INFLAMMATION 20 0.0021
389 BRAIN INJURY 21 0.0021
390 SHOCK HAEMORRHAGIC 17 0.0021
391 EMPHYSEMA 21 0.0021
392 DERMATITIS ALLERGIC 26 0.0021
393 UPPER-AIRWAY COUGH SYNDROME 17 0.0021
394 FIBROMYALGIA 50 0.0021
395 EOSINOPHIL COUNT INCREASED 17 0.0020
396 BACTERIAL INFECTION 38 0.0020
397 CYANOSIS 32 0.0020
398 BACTERAEMIA 24 0.0020
399 PHARYNGITIS 25 0.0020
400 TRICUSPID VALVE INCOMPETENCE 16 0.0020
401 THROMBOSIS 162 0.0020
402 MYOCLONUS 24 0.0020
403 HAEMOLYTIC ANAEMIA 18 0.0020
404 HEPATITIS ACUTE 13 0.0020
405 TRANSPLANT REJECTION 16 0.0020
406 RESPIRATORY FAILURE 145 0.0020
407 STREPTOCOCCAL INFECTION 11 0.0020
408 INTERNATIONAL NORMALISED RATIO INCREASED 56 0.0020
409 SPLENOMEGALY 23 0.0020
410 PERICARDIAL EFFUSION 45 0.0019
411 PNEUMONIA 626 0.0019
412 NEPHROPATHY 18 0.0019
413 SECRETION DISCHARGE 24 0.0019
414 URINARY TRACT INFECTION 326 0.0019
415 ABDOMINAL PAIN LOWER 48 0.0019
416 VISUAL ACUITY REDUCED 63 0.0019
417 CANDIDA INFECTION 32 0.0019
418 NOCTURIA 23 0.0019
419 HYPERTENSIVE CRISIS 21 0.0019
420 HEPATOTOXICITY 42 0.0019
421 TENDONITIS 29 0.0019
422 SKIN INFECTION 21 0.0019
423 AUTOIMMUNE HEPATITIS 13 0.0019
424 INFUSION SITE PAIN 24 0.0019
425 UPPER RESPIRATORY TRACT INFECTION 86 0.0019
426 LIVER FUNCTION TEST ABNORMAL 54 0.0019
427 SLEEP APNOEA SYNDROME 35 0.0018
428 POLYP 12 0.0018
429 HEPATOMEGALY 18 0.0018
430 SINUS TACHYCARDIA 26 0.0018
431 SKIN LESION 50 0.0018
432 ACUTE RESPIRATORY FAILURE 35 0.0018
433 MATERNAL EXPOSURE DURING PREGNANCY 162 0.0018
434 RESPIRATORY DISTRESS 50 0.0018
435 PLEURAL EFFUSION 110 0.0018
436 RESPIRATORY RATE INCREASED 16 0.0018
437 CARDIAC FAILURE ACUTE 12 0.0018
438 HAEMODIALYSIS 15 0.0018
439 RASH PUSTULAR 13 0.0018
440 MYOSITIS 16 0.0018
441 SENSATION OF FOREIGN BODY 15 0.0018
442 INFUSION SITE ERYTHEMA 15 0.0018
443 CONJUNCTIVITIS 33 0.0018
444 HIATUS HERNIA 23 0.0018
445 STATUS EPILEPTICUS 20 0.0018
446 POST PROCEDURAL COMPLICATION 34 0.0018
447 PYREXIA 609 0.0018
448 UNEVALUABLE EVENT 133 0.0018
449 ATRIAL FLUTTER 14 0.0018
450 ORAL CANDIDIASIS 23 0.0017
451 CARDIAC ARREST 144 0.0017
452 TINNITUS 80 0.0017
453 HYPERKALAEMIA 61 0.0017
454 HYPOMAGNESAEMIA 24 0.0017
455 PAROSMIA 13 0.0017
456 EYELID OEDEMA 20 0.0017
457 HAEMATOCRIT DECREASED 34 0.0017
458 DIARRHOEA HAEMORRHAGIC 16 0.0017
459 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
460 COVID-19 PNEUMONIA 20 0.0017
461 NEPHROPATHY TOXIC 19 0.0017
462 TACHYCARDIA 149 0.0017
463 PRODUCT PREPARATION ISSUE 11 0.0017
464 HYPERLIPIDAEMIA 20 0.0017
465 OXYGEN SATURATION DECREASED 94 0.0017
466 NEUTROPHIL COUNT INCREASED 17 0.0017
467 DERMATITIS BULLOUS 12 0.0017
468 SKIN LACERATION 18 0.0017
469 LIP SWELLING 55 0.0016
470 BLOOD COUNT ABNORMAL 25 0.0016
471 APATHY 24 0.0016
472 PETECHIAE 17 0.0016
473 FEBRILE NEUTROPENIA 108 0.0016
474 HEPATIC FAILURE 49 0.0016
475 BLOOD CREATININE INCREASED 106 0.0016
476 SINUSITIS 166 0.0016
477 NERVE INJURY 18 0.0016
478 ANXIETY 460 0.0016
479 GOUT 29 0.0016
480 INFLAMMATION 83 0.0016
481 OSTEOARTHRITIS 68 0.0016
482 PNEUMONIA ASPIRATION 40 0.0016
483 NEUROTOXICITY 28 0.0016
484 OSTEOPENIA 24 0.0016
485 DRUG ERUPTION 28 0.0016
486 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
487 GENERALISED TONIC-CLONIC SEIZURE 26 0.0016
488 COLITIS 59 0.0016
489 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
490 HAEMATOMA 40 0.0015
491 HYPOTENSION 309 0.0015
492 TENDON RUPTURE 19 0.0015
493 SLEEP DISORDER 108 0.0015
494 ILEUS 19 0.0015
495 DERMATITIS 32 0.0015
496 BODY TEMPERATURE DECREASED 15 0.0015
497 CONDITION AGGRAVATED 460 0.0015
498 RENAL CYST 12 0.0015
499 BRADYCARDIA 80 0.0015
500 MUSCLE ATROPHY 19 0.0015
501 MELAENA 33 0.0015
502 ALANINE AMINOTRANSFERASE INCREASED 92 0.0015
503 MIOSIS 12 0.0015
504 RHINITIS 12 0.0015
505 CEREBRAL DISORDER 11 0.0015
506 MYASTHENIA GRAVIS 12 0.0015
507 ARTHROPOD BITE 11 0.0015
508 IMMUNOSUPPRESSION 13 0.0015
509 LYMPHADENOPATHY 52 0.0015
510 RESPIRATORY DEPRESSION 18 0.0015
511 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11 0.0015
512 POLYURIA 12 0.0015
513 OESOPHAGITIS 16 0.0015
514 ECCHYMOSIS 10 0.0015
515 CELLULITIS 73 0.0014
516 BLOOD BILIRUBIN INCREASED 39 0.0014
517 THROMBOCYTOPENIA 161 0.0014
518 HYPONATRAEMIA 81 0.0014
519 ORTHOSTATIC HYPOTENSION 25 0.0014
520 BLOOD PRESSURE DECREASED 95 0.0014
521 DEVICE RELATED INFECTION 22 0.0014
522 EYE HAEMORRHAGE 19 0.0014
523 MUSCLE RIGIDITY 17 0.0014
524 IRON DEFICIENCY ANAEMIA 13 0.0014
525 PNEUMOCYSTIS JIROVECII PNEUMONIA 14 0.0014
526 ASPARTATE AMINOTRANSFERASE INCREASED 74 0.0014
527 PARAESTHESIA ORAL 20 0.0014
528 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
529 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
530 CAESAREAN SECTION 16 0.0014
531 HYPERSENSITIVITY 255 0.0014
532 ASPIRATION 15 0.0014
533 PROTEINURIA 26 0.0014
534 PALLOR 37 0.0014
535 DYSPNOEA 768 0.0014
536 EAR INFECTION 36 0.0014
537 PERITONITIS 28 0.0014
538 ATAXIA 16 0.0013
539 CHOLECYSTITIS 16 0.0013
540 HYPOGLYCAEMIA 65 0.0013
541 URTICARIA 224 0.0013
542 INTESTINAL PERFORATION 15 0.0013
543 VENTRICULAR TACHYCARDIA 22 0.0013
544 GASTROOESOPHAGEAL REFLUX DISEASE 107 0.0013
545 OEDEMA PERIPHERAL 162 0.0013
546 ACUTE CORONARY SYNDROME 11 0.0013
547 ROTATOR CUFF SYNDROME 17 0.0013
548 URINARY INCONTINENCE 39 0.0013
549 DRUG INTOLERANCE 127 0.0013
550 SINUS DISORDER 26 0.0013
551 OEDEMA 71 0.0013
552 PANCREATITIS 69 0.0013
553 STAPHYLOCOCCAL INFECTION 43 0.0013
554 BLISTER 73 0.0013
555 EMOTIONAL DISTRESS 157 0.0013
556 HYPERGLYCAEMIA 47 0.0013
557 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
558 POST PROCEDURAL HAEMORRHAGE 15 0.0013
559 BRAIN OEDEMA 16 0.0013
560 LEUKOPENIA 63 0.0013
561 PRODUCT PRESCRIBING ERROR 30 0.0013
562 ACCIDENTAL OVERDOSE 46 0.0013
563 HEPATIC CYTOLYSIS 16 0.0013
564 CORONARY ARTERY DISEASE 38 0.0013
565 SCIATICA 20 0.0013
566 UVEITIS 17 0.0013
567 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
568 DYSPNOEA EXERTIONAL 47 0.0012
569 TENDERNESS 13 0.0012
570 EYE INFECTION 14 0.0012
571 ANAEMIA 236 0.0012
572 FLUID OVERLOAD 18 0.0012
573 PHARYNGEAL OEDEMA 19 0.0012
574 PANCYTOPENIA 69 0.0012
575 EAR PAIN 24 0.0012
576 DIPLOPIA 32 0.0012
577 VITAMIN D DEFICIENCY 12 0.0012
578 NO THERAPEUTIC RESPONSE 15 0.0012
579 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 64 0.0012
580 BODY TEMPERATURE INCREASED 25 0.0012
581 CARDIOMYOPATHY 18 0.0012
582 GENERALISED OEDEMA 15 0.0012
583 CHILLS 142 0.0012
584 EPILEPSY 37 0.0012
585 GASTRIC ULCER 23 0.0012
586 PULMONARY MASS 18 0.0012
587 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
588 ORAL PAIN 27 0.0012
589 GENERAL PHYSICAL HEALTH DETERIORATION 139 0.0012
590 PHARYNGITIS STREPTOCOCCAL 13 0.0012
591 HEPATOCELLULAR INJURY 17 0.0012
592 ABDOMINAL PAIN 277 0.0012
593 DYSPHAGIA 113 0.0012
594 LIVER INJURY 29 0.0012
595 HEMIPARESIS 20 0.0012
596 ERYTHEMA MULTIFORME 11 0.0012
597 TOOTH FRACTURE 13 0.0012
598 NEPHROLITHIASIS 54 0.0012
599 VIRAL INFECTION 39 0.0012
600 VENTRICULAR FIBRILLATION 13 0.0012
601 CARDIAC FAILURE CONGESTIVE 94 0.0012
602 COUGH 328 0.0012
603 RIB FRACTURE 24 0.0012
604 PERIPHERAL COLDNESS 16 0.0012
605 UNRESPONSIVE TO STIMULI 30 0.0012
606 RESPIRATORY ARREST 32 0.0012
607 DELUSION 18 0.0012
608 RHABDOMYOLYSIS 48 0.0011
609 PLATELET COUNT INCREASED 15 0.0011
610 HAEMOGLOBIN DECREASED 118 0.0011
611 DERMATITIS CONTACT 13 0.0011
612 DEHYDRATION 152 0.0011
613 PULMONARY CONGESTION 15 0.0011
614 CYST 14 0.0011
615 SKIN EXFOLIATION 95 0.0011
616 RASH GENERALISED 29 0.0011
617 POOR QUALITY SLEEP 24 0.0011
618 OESOPHAGEAL CARCINOMA 33 0.0011
619 INSURANCE ISSUE 17 0.0011
620 HEART RATE DECREASED 39 0.0011
621 HAEMATURIA 38 0.0011
622 BLADDER DISORDER 11 0.0011
623 HAEMATEMESIS 28 0.0011
624 IMPAIRED GASTRIC EMPTYING 15 0.0011
625 BLOOD IRON DECREASED 13 0.0011
626 HEPATITIS 28 0.0011
627 RASH ERYTHEMATOUS 52 0.0011
628 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
629 EAR DISCOMFORT 11 0.0011
630 IMPAIRED HEALING 35 0.0011
631 PNEUMONITIS 29 0.0011
632 PRURITUS GENERALISED 23 0.0011
633 EYE DISCHARGE 11 0.0011
634 HYPOCALCAEMIA 20 0.0011
635 PULMONARY HYPERTENSION 22 0.0011
636 PAIN IN EXTREMITY 309 0.0010
637 EYE SWELLING 39 0.0010
638 OSTEOPOROSIS 43 0.0010
639 MUSCULAR WEAKNESS 118 0.0010
640 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
641 LETHARGY 59 0.0010
642 BLOOD UREA INCREASED 17 0.0010
643 ANGINA PECTORIS 29 0.0010
644 NEUROLEPTIC MALIGNANT SYNDROME 12 0.0010
645 DISORIENTATION 40 0.0010
646 BLOOD SODIUM DECREASED 19 0.0010
647 EXTRAPYRAMIDAL DISORDER 25 0.0010
648 ATRIAL FIBRILLATION 98 0.0010
649 CEREBRAL HAEMORRHAGE 36 0.0010
650 PULMONARY OEDEMA 45 0.0010
651 OBESITY 16 0.0010
652 ABSCESS 16 0.0010
653 FOOT FRACTURE 19 0.0010
654 DEEP VEIN THROMBOSIS 65 0.0010
655 NERVOUS SYSTEM DISORDER 31 0.0010
656 LOCALISED INFECTION 24 0.0010
657 BONE DENSITY DECREASED 31 0.0010
658 BURSITIS 12 0.0010
659 MOBILITY DECREASED 71 0.0010
660 IMMUNE SYSTEM DISORDER 13 0.0010
661 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
662 AGITATION 72 0.0010
663 FISTULA 11 0.0010
664 PROCEDURAL PAIN 27 0.0010
665 BLOOD CREATINE PHOSPHOKINASE INCREASED 28 0.0010
666 INTERSTITIAL LUNG DISEASE 47 0.0010
667 PHOTOSENSITIVITY REACTION 16 0.0010
668 ANOSMIA 14 0.0010
669 HEPATIC STEATOSIS 18 0.0010
670 ERYTHEMA 198 0.0010
671 GASTROINTESTINAL HAEMORRHAGE 80 0.0010
672 BLINDNESS 39 0.0010
673 THERAPY NON-RESPONDER 43 0.0010
674 INFECTION 138 0.0010
675 CYTOKINE RELEASE SYNDROME 19 0.0009
676 OSTEOMYELITIS 17 0.0009
677 SEROTONIN SYNDROME 18 0.0009
678 HAEMORRHAGE INTRACRANIAL 14 0.0009
679 RASH 408 0.0009
680 SCAR 16 0.0009
681 OROPHARYNGEAL PAIN 86 0.0009
682 HAEMATOCHEZIA 51 0.0009
683 ORAL HERPES 18 0.0009
684 ACCIDENT 11 0.0009
685 ABDOMINAL DISTENSION 96 0.0009
686 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
687 DIARRHOEA 589 0.0009
688 LACTIC ACIDOSIS 29 0.0009
689 CONSTIPATION 195 0.0009
690 DELIRIUM 31 0.0009
691 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
692 HYPERCALCAEMIA 11 0.0009
693 HALLUCINATION 67 0.0009
694 IMPAIRED WORK ABILITY 19 0.0009
695 RASH MACULAR 31 0.0009
696 DYSKINESIA 36 0.0009
697 FLUID RETENTION 45 0.0009
698 CARDIAC FAILURE 71 0.0009
699 RESPIRATORY TRACT CONGESTION 14 0.0009
700 VOMITING 414 0.0009
701 DYSARTHRIA 33 0.0009
702 HAEMORRHOIDS 17 0.0009
703 MUSCULOSKELETAL DISCOMFORT 15 0.0009
704 RESPIRATORY DISORDER 26 0.0009
705 MENTAL STATUS CHANGES 24 0.0009
706 PRODUCT USE IN UNAPPROVED INDICATION 214 0.0009
707 HYPOPHAGIA 22 0.0009
708 MIGRAINE 82 0.0009
709 MYALGIA 146 0.0009
710 MOUTH ULCERATION 18 0.0009
711 VERTIGO 52 0.0009
712 PANCREATITIS ACUTE 19 0.0008
713 SWELLING 79 0.0008
714 CHROMATURIA 19 0.0008
715 STOMATITIS 51 0.0008
716 ABDOMINAL PAIN UPPER 173 0.0008
717 FUNGAL INFECTION 28 0.0008
718 JOINT STIFFNESS 22 0.0008
719 GASTRITIS 22 0.0008
720 LOSS OF CONSCIOUSNESS 107 0.0008
721 SARS-COV-2 TEST POSITIVE 11 0.0008
722 LACRIMATION INCREASED 25 0.0008
723 DYSTONIA 16 0.0008
724 PNEUMOTHORAX 13 0.0008
725 DYSURIA 30 0.0008
726 ENCEPHALOPATHY 20 0.0008
727 ACUTE MYOCARDIAL INFARCTION 24 0.0008
728 BACK PAIN 189 0.0008
729 DEPRESSION 185 0.0008
730 SKIN ULCER 21 0.0008
731 URINARY RETENTION 27 0.0008
732 TOXICITY TO VARIOUS AGENTS 136 0.0008
733 ASTHENIA 303 0.0008
734 RHINORRHOEA 52 0.0008
735 CHEST PAIN 149 0.0008
736 COMA 38 0.0008
737 NEUTROPENIA 108 0.0008
738 RENAL DISORDER 37 0.0008
739 LYMPHOCYTE COUNT DECREASED 14 0.0008
740 HEAD DISCOMFORT 14 0.0008
741 SYNCOPE 79 0.0008
742 MASS 11 0.0008
743 DEVICE OCCLUSION 11 0.0008
744 CEREBRAL INFARCTION 19 0.0008
745 LIMB DISCOMFORT 24 0.0008
746 GASTROENTERITIS VIRAL 14 0.0008
747 LUNG INFECTION 12 0.0008
748 EJECTION FRACTION DECREASED 12 0.0008
749 CHOKING 15 0.0008
750 BONE PAIN 45 0.0008
751 CARDIO-RESPIRATORY ARREST 32 0.0008
752 BLOOD POTASSIUM DECREASED 23 0.0008
753 KIDNEY INFECTION 15 0.0008
754 DISTURBANCE IN ATTENTION 41 0.0008
755 ARRHYTHMIA 36 0.0008
756 RASH PAPULAR 17 0.0008
757 CONTUSION 73 0.0008
758 ADVERSE REACTION 10 0.0008
759 UPPER LIMB FRACTURE 15 0.0008
760 FALL 250 0.0008
761 ARTHRITIS 59 0.0007
762 HYPERTENSION 158 0.0007
763 PRESYNCOPE 18 0.0007
764 MALAISE 324 0.0007
765 BONE MARROW FAILURE 15 0.0007
766 LIMB INJURY 20 0.0007
767 DRUG TOXICITY 10 0.0007
768 OFF LABEL USE 640 0.0007
769 GALLBLADDER DISORDER 13 0.0007
770 AGEUSIA 18 0.0007
771 RECTAL HAEMORRHAGE 31 0.0007
772 SKIN DISORDER 24 0.0007
773 HEPATIC ENZYME INCREASED 49 0.0007
774 TOOTHACHE 13 0.0007
775 FEELING HOT 44 0.0007
776 APHONIA 10 0.0007
777 MOVEMENT DISORDER 23 0.0007
778 THROAT IRRITATION 32 0.0007
779 COVID-19 124 0.0007
780 HYPERHIDROSIS 91 0.0007
781 ACUTE MYELOID LEUKAEMIA 11 0.0007
782 DRUG EXPOSURE DURING PREGNANCY 24 0.0007
783 FLATULENCE 40 0.0007
784 BLOOD PRESSURE ABNORMAL 14 0.0007
785 THROAT TIGHTNESS 19 0.0007
786 CHOLELITHIASIS 23 0.0007
787 RASH PRURITIC 38 0.0007
788 RED BLOOD CELL COUNT DECREASED 20 0.0007
789 NECK PAIN 39 0.0007
790 DECREASED APPETITE 162 0.0007
791 HEAD INJURY 22 0.0007
792 WEIGHT DECREASED 194 0.0007
793 PAIN 426 0.0007
794 PHOTOPHOBIA 13 0.0007
795 TASTE DISORDER 14 0.0007
796 PERIPHERAL SWELLING 106 0.0007
797 PRURITUS 263 0.0007
798 NIGHT SWEATS 22 0.0007
799 NASAL CONGESTION 40 0.0007
800 WOUND 19 0.0007
801 CHEST DISCOMFORT 69 0.0007
802 CARDIOVASCULAR DISORDER 17 0.0007
803 SNEEZING 15 0.0007
804 INTESTINAL OBSTRUCTION 25 0.0007
805 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
806 PANIC ATTACK 24 0.0007
807 GAIT INABILITY 22 0.0007
808 NEURALGIA 16 0.0007
809 RESTLESSNESS 24 0.0007
810 LIVER DISORDER 29 0.0007
811 CONFUSIONAL STATE 105 0.0006
812 ANKLE FRACTURE 10 0.0006
813 INFLUENZA 72 0.0006
814 DEMENTIA 18 0.0006
815 HEPATIC FUNCTION ABNORMAL 24 0.0006
816 DIZZINESS 320 0.0006
817 CATARACT 38 0.0006
818 BLOOD PRESSURE INCREASED 97 0.0006
819 FRACTURE 12 0.0006
820 HEADACHE 397 0.0006
821 WRONG TECHNIQUE IN DRUG USAGE PROCESS 23 0.0006
822 MEDICATION ERROR 35 0.0006
823 PARAESTHESIA 99 0.0006
824 APHASIA 19 0.0006
825 HYPOAESTHESIA 94 0.0006
826 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
827 HIP FRACTURE 20 0.0006
828 HERNIA 12 0.0006
829 TREMOR 103 0.0006
830 DYSPEPSIA 61 0.0006
831 FLUSHING 63 0.0006
832 ISCHAEMIC STROKE 11 0.0006
833 BLOOD POTASSIUM INCREASED 10 0.0006
834 HALLUCINATION, VISUAL 13 0.0006
835 EATING DISORDER 13 0.0006
836 SKIN DISCOLOURATION 28 0.0006
837 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
838 EYE PAIN 34 0.0006
839 SPINAL FRACTURE 12 0.0006
840 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
841 NAUSEA 460 0.0006
842 MYOCARDIAL INFARCTION 101 0.0006
843 FATIGUE 449 0.0006
844 NASOPHARYNGITIS 106 0.0006
845 MENTAL DISORDER 25 0.0006
846 ILLNESS 59 0.0006
847 LOWER LIMB FRACTURE 11 0.0006
848 ERUCTATION 11 0.0006
849 DRY MOUTH 46 0.0006
850 BALANCE DISORDER 49 0.0006
851 ABASIA 14 0.0006
852 LIVER FUNCTION TEST INCREASED 12 0.0006
853 MYELOSUPPRESSION 20 0.0006
854 VISUAL IMPAIRMENT 68 0.0005
855 GASTROINTESTINAL DISORDER 49 0.0005
856 FULL BLOOD COUNT DECREASED 11 0.0005
857 HEART RATE INCREASED 54 0.0005
858 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
859 FEEDING DISORDER 11 0.0005
860 PSYCHOTIC DISORDER 16 0.0005
861 ARTHROPATHY 30 0.0005
862 HERPES ZOSTER 31 0.0005
863 ARTHRALGIA 224 0.0005
864 DIABETES MELLITUS 41 0.0005
865 NEUROPATHY PERIPHERAL 51 0.0005
866 DRUG INEFFECTIVE 706 0.0005
867 MUCOSAL INFLAMMATION 14 0.0005
868 MUSCULOSKELETAL PAIN 28 0.0005
869 TARDIVE DYSKINESIA 15 0.0005
870 DISCOMFORT 32 0.0005
871 NEOPLASM PROGRESSION 18 0.0005
872 HAEMORRHAGE 54 0.0005
873 RETCHING 11 0.0005
874 COLITIS ULCERATIVE 23 0.0005
875 GASTRIC CANCER 13 0.0005
876 MUSCLE SPASMS 94 0.0005
877 TREATMENT NONCOMPLIANCE 28 0.0005
878 HYPOACUSIS 22 0.0005
879 DEPRESSED MOOD 27 0.0005
880 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
881 TYPE 2 DIABETES MELLITUS 17 0.0005
882 FEELING COLD 14 0.0005
883 DEAFNESS 13 0.0005
884 VISION BLURRED 68 0.0005
885 PAIN IN JAW 14 0.0005
886 COGNITIVE DISORDER 23 0.0005
887 SOMNOLENCE 99 0.0005
888 DRUG ADMINISTRATION ERROR 15 0.0005
889 HOSPITALISATION 75 0.0005
890 PLATELET COUNT DECREASED 52 0.0005
891 THERAPY CESSATION 25 0.0005
892 HEART RATE IRREGULAR 11 0.0005
893 INFLUENZA LIKE ILLNESS 40 0.0005
894 DISEASE RECURRENCE 23 0.0005
895 DISEASE PROGRESSION 57 0.0005
896 EPISTAXIS 36 0.0005
897 SPEECH DISORDER 25 0.0005
898 GAIT DISTURBANCE 90 0.0005
899 CEREBROVASCULAR ACCIDENT 79 0.0005
900 SUICIDE ATTEMPT 28 0.0005
901 PLASMA CELL MYELOMA 18 0.0005
902 DIABETIC KETOACIDOSIS 11 0.0005
903 PRODUCT USE ISSUE 86 0.0005
904 FEELING ABNORMAL 109 0.0005
905 CONVULSION 26 0.0005
906 ABNORMAL BEHAVIOUR 18 0.0005
907 AMNESIA 29 0.0004
908 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
909 NEUTROPHIL COUNT DECREASED 18 0.0004
910 INTENTIONAL PRODUCT USE ISSUE 38 0.0004
911 THERAPY INTERRUPTED 31 0.0004
912 POLLAKIURIA 18 0.0004
913 DYSGEUSIA 32 0.0004
914 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
915 DRY EYE 21 0.0004
916 SEDATION 11 0.0004
917 WEIGHT INCREASED 94 0.0004
918 PALPITATIONS 49 0.0004
919 CARDIAC DISORDER 38 0.0004
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
921 ECZEMA 21 0.0004
922 ABDOMINAL DISCOMFORT 66 0.0004
923 INFUSION RELATED REACTION 26 0.0004
924 HYPERSOMNIA 11 0.0004
925 PRODUCT DOSE OMISSION 25 0.0004
926 IRRITABILITY 23 0.0004
927 ILL-DEFINED DISORDER 23 0.0004
928 DYSSTASIA 11 0.0004
929 INJECTION SITE BRUISING 30 0.0004
930 OVERDOSE 81 0.0004
931 SURGERY 22 0.0004
932 DEATH 323 0.0004
933 PRODUCT DOSE OMISSION ISSUE 110 0.0004
934 LABORATORY TEST ABNORMAL 11 0.0004
935 SEIZURE 43 0.0004
936 MALIGNANT NEOPLASM PROGRESSION 38 0.0004
937 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
938 OSTEONECROSIS 12 0.0004
939 ROAD TRAFFIC ACCIDENT 15 0.0004
940 OCULAR HYPERAEMIA 17 0.0004
941 FEMUR FRACTURE 11 0.0004
942 VAGINAL HAEMORRHAGE 15 0.0003
943 DEVICE DISLOCATION 15 0.0003
944 INTENTIONAL OVERDOSE 22 0.0003
945 ACCIDENTAL EXPOSURE TO PRODUCT 35 0.0003
946 MEMORY IMPAIRMENT 46 0.0003
947 EYE DISORDER 11 0.0003
948 INSOMNIA 89 0.0003
949 NERVOUSNESS 17 0.0003
950 BLOOD CHOLESTEROL INCREASED 15 0.0003
951 SKIN BURNING SENSATION 23 0.0003
952 PSORIATIC ARTHROPATHY 13 0.0003
953 MUSCULOSKELETAL STIFFNESS 28 0.0003
954 BURNING SENSATION 22 0.0003
955 INJECTION SITE SWELLING 24 0.0003
956 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
957 JOINT SWELLING 37 0.0003
958 ADVERSE EVENT 28 0.0003
959 ABORTION SPONTANEOUS 12 0.0003
960 HOT FLUSH 22 0.0003
961 ADVERSE DRUG REACTION 26 0.0003
962 PSORIASIS 37 0.0003
963 AGGRESSION 14 0.0003
964 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
965 CRYING 10 0.0003
966 BLOOD GLUCOSE DECREASED 13 0.0003
967 ALOPECIA 53 0.0003
968 RHEUMATOID ARTHRITIS 30 0.0003
969 ACNE 20 0.0003
970 SUICIDAL IDEATION 24 0.0003
971 EYE IRRITATION 15 0.0003
972 NEOPLASM MALIGNANT 17 0.0003
973 TREATMENT FAILURE 20 0.0002
974 BLOOD GLUCOSE INCREASED 43 0.0002
975 DRY SKIN 29 0.0002
976 INCORRECT DOSE ADMINISTERED 49 0.0002
977 PRODUCT QUALITY ISSUE 28 0.0002
978 DRUG EFFECT DECREASED 11 0.0002
979 THERAPEUTIC RESPONSE DECREASED 12 0.0002
980 INJECTION SITE PAIN 55 0.0002
981 UNDERDOSE 12 0.0002
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
983 INJECTION SITE ERYTHEMA 20 0.0002
984 DRUG WITHDRAWAL SYNDROME 14 0.0002
985 DRUG ABUSE 13 0.0002
986 BREAST CANCER 14 0.0002
987 DRUG DOSE OMISSION 23 0.0001
988 INTENTIONAL PRODUCT MISUSE 11 0.0001
989 DEVICE ISSUE 10 0.0001
990 NO ADVERSE EVENT 15 0.0001
991 DRUG DEPENDENCE 13 0.0001